LSC - 2021 - Mapping of Kras mutations during chemical carcinogenesis

B. Sabine, M. Spella (magsp@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), M. A. A. Pepe (mario.pepe@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), G. A. Giotopoulou (georgia.giotopoulou@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), M. Lianou (lianou@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), I. Giopanou (giopanou@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), A. Lamort (anne-sophie.lamort@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), G. T. Stathopoulos (stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich)

Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Session: Biology of lung cancer: preclinical and translational research
Session type: E-poster
Number: 1115

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Sabine, M. Spella (magsp@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), M. A. A. Pepe (mario.pepe@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), G. A. Giotopoulou (georgia.giotopoulou@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), M. Lianou (lianou@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), I. Giopanou (giopanou@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), A. Lamort (anne-sophie.lamort@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), G. T. Stathopoulos (stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich). LSC - 2021 - Mapping of Kras mutations during chemical carcinogenesis. 1115

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PP134 – Mapping of Kras mutations during chemical carcinogenesis
Source: ERS Lung Science Conference 2021
Year: 2021

Mapping of Kras mutations during chemical carcinogenesis
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021


Mapping of KRAS mutations during chemical carcinogenesis
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


LSC - 2021 - Mutational RNA signatures in environmentally-induced lung adenocarcinoma
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



LSC - 2017 - KRAS & TP53 mutations cause malignant mesothelioma
Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside
Year: 2017

LSC - 2021 - COL4A3 expression in asthmatic epithelium depends on intronic methylation and ZNF263 binding
Source: Virtual Congress 2021 – Environment and air pollution
Year: 2021


LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017

LSC - 2021 - Regulation of PA200 in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


LSC - 2020 - Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer
Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Year: 2020

NKX2-1 impacts prognosis in early stage NSCLC not harboring TP53 mutations
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

LSC - 2020 - Comprehensive characterization of the immune landscape within different molecular subtypes of small cell lung cancer (SCLC)
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020




Target other gene point mutations: HER2 and rare EGFR mutations
Source: ERS Research Seminar
Year: 2015

Frequency and clinical-tomographic characterization of NSCLC with T790M mutation to TKI progression.
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019


Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients
Source: Eur Respir Rev 2014; 23: 390-392
Year: 2014


LSC 2014 abstract - Phenotypic, transcriptomic and epigenetic plasticity of dendritic cells in the lung tumor microenvironment reflects imprinting by hypoxia exposure
Source: International Congress 2014 – Thoracic tumours: news from the lab
Year: 2014

p53 gene mutations in lung cancer in Korean
Source: Eur Respir J 2005; 26: Suppl. 49, 327s
Year: 2005

Defining lineage relationships of multiple lung tumors through shared large genomic rearrangements
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

LSC - 2017 - Deregulated SOX2 drives a migratory signature in a novel organotypic model of bronchial dysplasia
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

Mutation of TP53 and KRAS, and loss of p16ink4a and p14arf expression in lung cancers in relation to tobacco smoke
Source: Eur Respir J 2005; 26: Suppl. 49, 93s
Year: 2005